Live Breaking News & Updates on Rafael Bejar

Stay updated with breaking news from Rafael bejar. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Aptose to Report First Quarter 2024 Financial Results and Provide Clinical Strategy Update on Tuesday, May 14, 2024

Aptose to Report First Quarter 2024 Financial Results and Provide Clinical Strategy Update on Tuesday, May 14, 2024
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Rafael Bejar , Susan Pietropaolo , Aptose Biosciences , Lifesci Advisors , Aptose Biosciences Inc , Corporate Communications Investor Relations , Report First Quarter , Provide Clinical Strategy Update , Chief Medical Officer , Key Opinion Leader , Investor Relations , Sci Advisors ,

Aptose Biosciences Inc. (NASDAQ:APTO) Q4 2023 Earnings Call Transcript

Operator: Good afternoon. My name is Jonathan and I will be your conference operator today. ....

Soumit Roy , Aptose Biosciences , Susan Pietropaolo , William Rice , Rafael Bejar , Fletcher Payne , Md Anderson Cancer Center , Aptose Biosciences Inc , Jones Research , Call Transcript March , Aptose Biosciences Conference Call , Fourth Quarter , Year Ended December , Senior Vice President , Chief Medical Officer , Chief Financial , Naval Daver , Cancer Center , Chief Business Officer , Hanmi Pharmaceutical ,

Aptose Tuspetinib Clinical Data Featured in Oral Presentation at the 2023 ASH Annual Meeting

Aptose Tuspetinib Clinical Data Featured in Oral Presentation at the 2023 ASH Annual Meeting
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , Aptose Biosciences , Rafael Bejar , Exchange Commission , International Phase , University Of Texas Md Anderson Cancer Center , Aptosebiosciencesinc Susan Pietropaolocorporate Communications Investor Relations , Leukemia Research Alliance Program , Aptose Biosciences Inc , American Society Of Hematology , Department Of Leukemia , Reporting Complete Response Data , Demonstrate Favorable Safety , Active Across Broad Populations , Complete Response Rate Among All Comers , Achieve Responses , Patients Receiving , Snow Over , American Society , Annual Meeting , Director Leukemia Research Alliance Program , Cancer Center , Chief Medical Officer , United States Securities , Investor Relations , Managing Director ,

Aptose Tuspetinib Clinical Data Featured in Oral

Aptose Tuspetinib Clinical Data Featured in Oral
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.

United States , Rafael Bejar , Susan Pietropaolo , Aptose Biosciences , Corporate Communications Investor Relations , International Phase , Aptose Biosciences Inc , University Of Texas Md Anderson Cancer Center , American Society Of Hematology , Department Of Leukemia , Exchange Commission , Leukemia Research Alliance Program , Reporting Complete Response Data , Demonstrate Favorable Safety , Active Across Broad Populations , Complete Response Rate Among All Comers , Achieve Responses , Patients Receiving , Snow Over , American Society , Annual Meeting , Director Leukemia Research Alliance Program , Cancer Center , Chief Medical Officer , United States Securities ,

Aptose Presents Highlights from Clinical Update Webcast Featuring Latest Available Data on AML Drug Tuspetinib

Aptose Presents Highlights from Clinical Update Webcast Featuring Latest Available Data on AML Drug Tuspetinib
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United States , Susan Pietropaolo , Rafael Bejar , Aptose Biosciences , Aptose Biosciences Inc , Leukemia Research Alliance Program , University Of Texas Md Anderson Cancer Center , European School Of Haematology , Department Of Leukemia , International Conference , Exchange Commission , Lifesci Advisors , Presents Highlights , Clinical Findings , Heavily Pre Treated , Favorable Safety , European School , Acute Myeloid Leukemia , Chief Medical Officer , Director Leukemia Research Alliance Program , Cancer Center , Response Rates , United States Securities , Sci Advisors ,